Why IDEAYA Biosciences Shares Plunging Today
Earlier today, IDEAYA Biosciences Inc (NASDAQ:IDYA) reported Q2 results, and shares have plunged 30% after the update. Investors are probably reacting…
ContraFect Cuts Workforce After Trial Setback
ContraFect Corporation (NASDAQ:CFRX) said it continues to advance lead programs toward new clinical studies and expects to file with regulatory authorities…
FDA Clears Organogenesis’ Next Generation PuraPly Surgical Solution
Organogenesis Holdings Inc (NASDAQ:ORGO) has received the FDA 510k Clearance for PuraPly MZ, a brand extension to the PuraPly product portfolio. …
Horizon Therapeutics Inks Option Agreement For Atopic Dermatitis Candidate
Q32 Bio and Horizon Therapeutics plc (NASDAQ:HZNP) entered into a collaboration and option agreement to develop ADX-914 for autoimmune diseases. ADX-914 is…
Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart
Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.
Gilead Shares Climb On Positive Interim Analysis From Late-Stage Breast Cancer Study
Gilead Sciences, Inc. (NASDAQ: GILD) announced positive results from the second interim analysis of the key secondary endpoint of overall survival (OS) in the Phase 3 TROPiCS-02 study evaluating Trodelvy (sacituzumab govitecan-hziy) in patients with HR+/HER2- metastatic breast cancer.
BrainStorm To File US Application For NurOwn In Amyotrophic Lateral Sclerosis
BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) announced its decision to submit a marketing application to the FDA seeking approval for NurOwn for…
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.
Novavax Seeks FDA Emergency Use Nod For Its COVID-19 Vaccine Booster
Novavax Inc (NASDAQ:NVAX) has submitted an application to the FDA for Emergency Use Authorization (EUA) for its protein-based COVID-19 vaccine as…
Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements
Clene Inc (NASDAQ:CLNN) has announced topline results from the Phase 2 VISIONARY-MS trial of CNM-Au, an investigational gold nanocrystal suspension, in…